Regular Article
Assignment of O-Glycan Attachment Sites to the Hinge-like Regions of Human Lysosomal Membrane Glycoproteins Lamp-1 and Lamp-2

https://doi.org/10.1006/abbi.1993.1322Get rights and content

Abstract

The lysosomal membrane glycoproteins lamp-1 and lamp-2 are extensively glycosylated with a variety of different carbohydrate structures of both N-linked and O-linked type. In the present paper, we report the localization of O-linked oligosaccharides exclusively to the hinge-like regions of lamp-1 and lamp-2 isolated from human chronic myelogenous leukemia cells. In both glycoproteins, the O-glycans appear in clusters. In lamp-1, Thr-171, Thr-172, Ser-179, Ser-181, and Ser-183 were fully glycosylated, whereas Ser-169 was partially glycosylated. In lamp-2, complete glycosylation was found at Ser-167, Thr-168, Thr-172, Thr-175, Thr-176, Thr-182, and Thr-183, and partial glycosylation at Ser-179 and Thr-181, and possibly also at Thr-185. The amino acid sequences of these O-glycosylation sites are consistent with the previous reports that residues at positions −1 and +3 may influence the glycosylation reaction. Circular dichroism and nuclear magnetic resonance spectroscopy was used for the structural characterization of a synthetic peptide corresponding to residues 167 to 190 of lamp-1. The results indicated that the proline-rich O-glycan acceptor region does not adopt any typical periodic structure but differs from random-coil structure. The circular dichroism spectrum of the peptide is, however, similar to that of porcine submaxillary apomucin. A significant conformational variability was observed in this region, presumably due to a slow (on the nuclear magnetic resonance time scale) cis-trans isomerization of several proline residues. These results, taken together, strongly suggest that a hinge region does not display any typical ordered structure. The presence of O-glycans thus likely protects this region from intralumenal lysosomal proteases.

References (0)

Cited by (41)

  • The two-domain architecture of LAMP2A regulates its interaction with Hsc70

    2022, Experimental Cell Research
    Citation Excerpt :

    Previously, we proposed that the linker regions are perpendicular to the membrane along the C-domains [18]. The linker regions are expected to be elongated and rigid after O-glycosylation [35]. With this model, the presence of the linker regions can explain the steric hindrance of AlocLys at the edge of side A and the occupation of pBpa in the central part, by forming the cavity between the two LAMP2A molecules (Fig. S5B).

  • Lysosome-associated membrane proteins (LAMPs) regulate intracellular positioning of mitochondria in MC3T3-E1 cells

    2015, Experimental Cell Research
    Citation Excerpt :

    Although mouse LAMP-1 and LAMP-2 are composed of 406 and 415 amino acid residues, respectively, LAMP-1 migrated much faster than LAMP-2 after the N-glycosylation removal. This can be explained by the fact that LAMP-2 has more O-linked glycosylation sites in the linker region between the two domains than LAMP-1, in the case of the human proteins [24]. After the treatment with the LAMP-2 siRNA, the amount of LAMP-2 was appreciably decreased (Fig. 3B), without affecting LAMP-1 expression, indicating that the siRNA acted specifically on LAMP-2.

  • Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes

    2015, Journal of Biological Chemistry
    Citation Excerpt :

    We decided to investigate the cause for the differences in mobility of the LAMPs in the Pompe iPSC-CMs by focusing on glycosylation, as both of these proteins are heavily glycosylated by traditional N- and O-linked endoplasmic reticulum (ER)-to-Golgi glycan biosynthesis pathways. In addition, several of the N-linked adducts are modified by long poly-N-acetyllactosamines added in the Golgi apparatus (38–41). To test the hypothesis that a deficit in Golgi-based glycosylation is the source of lower molecular weight LAMP species, iPSC-CMs were exposed to brefeldin A (BFA), a fungal metabolite that causes collapse of the Golgi stacks, disrupting Golgi-based glycosylation (42).

View all citing articles on Scopus
View full text